person

Arnaud J.

Country
France
Department
Hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
103
Sites with multiple studies

Has run more than one trial at 103 of 226 partner sites.

Specializations

Multiple Myeloma Research

The investigator specializes in treating multiple myeloma, with particular emphasis on novel therapeutic combinations for both newly diagnosed and relapsed cases. Their work includes studies of daratumumab-based regimens and treatment approaches for transplant-ineligible elderly patients.

  • Treatment of frail and elderly patients
  • Novel drug combinations
  • High-risk smoldering myeloma

A significant focus is placed on optimizing treatment duration and exploring subcutaneous administration methods.

AL Amyloidosis Studies

The investigator conducts extensive research in light chain (AL) amyloidosis, investigating innovative therapeutic approaches for both newly diagnosed and refractory cases. Their work encompasses evaluation of targeted therapies and combination treatments.

  • Mayo Stage IV disease management
  • Novel therapeutic combinations
  • Refractory disease treatment

Research includes assessment of hematologic responses and survival outcomes in various treatment protocols.

Hematologic Malignancies

The investigator's expertise extends to various hematologic conditions, including research in myelofibrosis and acute leukemia. Their work includes innovative transplantation approaches and immunotherapy strategies.

  • Haplo-identical transplantation
  • Immunization protocols
  • Treatment of lymphomas

Focus areas include disease-free survival outcomes and immune response optimization in blood cancer patients.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.